Lifecore Biomedical (LFCR) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Lifecore Biomedical Revenue Highlights


Latest Revenue (Y)

$128.26M

Latest Revenue (Q)

$35.70M

Lifecore Biomedical Revenue by Period


Lifecore Biomedical Revenue by Year

DateRevenueChange
2024-05-26$128.26M24.20%
2023-05-28$103.27M-44.42%
2022-05-29$185.79M-65.86%
2021-05-31$544.16M-7.83%
2020-05-31$590.37M5.88%
2019-05-31$557.56M6.36%
2018-05-31$524.23M-1.51%
2017-05-31$532.26M-1.63%
2016-05-31$541.10M0.34%
2015-05-31$539.26M13.10%
2014-05-31$476.81M7.95%
2013-05-31$441.71M39.10%
2012-05-31$317.55M14.75%
2011-05-31$276.73M16.16%
2010-05-31$238.22M0.97%
2009-05-31$235.94M-1.09%
2008-05-31$238.53M13.32%
2007-05-31$210.50M-9.25%
2006-05-31$231.95M13.02%
2005-05-31$205.23M6.84%
2004-05-31$192.09M100.00%
2003-05-31--100.00%
2002-10-31$183.16M-4.05%
2001-10-31$190.88M-8.91%
2000-10-31$209.55M491.95%
1999-10-31$35.40M5.67%
1998-10-31$33.50M252.63%
1997-10-31$9.50M280.00%
1996-10-31$2.50M-

Lifecore Biomedical generated $128.26M in revenue during NA 2024, up 24.20% compared to the previous quarter, and up 23.00% compared to the same period a year ago.

Lifecore Biomedical Revenue by Quarter

DateRevenueChange
2024-02-25$35.70M18.42%
2023-11-26$30.15M22.95%
2023-08-27$24.52M-22.27%
2023-05-28$31.55M14.30%
2023-02-26$27.60M-28.87%
2022-11-27$38.80M-10.50%
2022-08-28$43.35M-8.97%
2022-05-29$47.63M-10.26%
2022-02-28$53.07M-59.01%
2021-11-30$129.49M0.55%
2021-08-31$128.79M-7.90%
2021-05-31$139.83M1.49%
2021-02-28$137.78M5.25%
2020-11-30$130.90M-3.49%
2020-08-31$135.64M-13.12%
2020-05-31$156.13M2.09%
2020-02-29$152.93M7.25%
2019-11-30$142.59M2.80%
2019-08-31$138.71M-9.21%
2019-05-31$152.78M-1.87%
2019-02-28$155.69M24.64%
2018-11-30$124.91M0.20%
2018-08-31$124.67M-11.63%
2018-05-31$141.08M-5.52%
2018-02-28$149.32M9.43%
2017-11-30$136.46M10.62%
2017-08-31$123.36M-3.20%
2017-05-31$127.43M-6.69%
2017-02-28$136.57M0.52%
2016-11-30$135.87M2.62%
2016-08-31$132.39M-2.16%
2016-05-31$135.31M4.09%
2016-02-29$129.99M-7.44%
2015-11-30$140.44M8.04%
2015-08-31$129.99M-3.32%
2015-05-31$134.45M0.62%
2015-02-28$133.61M0.72%
2014-11-30$132.66M-4.23%
2014-08-31$138.53M14.55%
2014-05-31$120.93M10.46%
2014-02-28$109.48M-8.79%
2013-11-30$120.03M-5.03%
2013-08-31$126.38M17.99%
2013-05-31$107.11M4.94%
2013-02-28$102.07M-10.97%
2012-11-30$114.65M-2.73%
2012-08-31$117.87M42.67%
2012-05-31$82.62M12.71%
2012-02-29$73.30M-10.14%
2011-11-30$81.57M1.88%
2011-08-31$80.06M17.57%
2011-05-31$68.10M4.84%
2011-02-28$64.95M-7.43%
2010-11-30$70.17M-4.55%
2010-08-31$73.51M26.27%
2010-05-31$58.22M-4.47%
2010-02-28$60.94M0.02%
2009-11-30$60.93M4.82%
2009-08-31$58.13M11.29%
2009-05-31$52.24M-27.20%
2009-02-28$71.75M23.63%
2008-11-30$58.04M7.66%
2008-08-31$53.91M-5.91%
2008-05-31$57.30M-

Lifecore Biomedical generated $35.70M in revenue during Q3 2024, up 18.42% compared to the previous quarter, and up 92.02% compared to the same period a year ago.

Lifecore Biomedical Revenue Breakdown


Lifecore Biomedical Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceMay 24
Product and Service, Other-

Quarterly Revenue by Product

Product/ServiceFeb 23Nov 22
Other Segments--

Lifecore Biomedical Revenue Breakdown by Country

Quarterly Revenue by Country

CountryFeb 23Nov 22
CZECHIA$700.00K$1.00M
SWITZERLAND$6.80M$4.00M
IRELAND$1.10M$1.00M
AUSTRALIA$1.10M-
All Other Countries$200.00K$500.00K
CANADA$700.00K$2.60M

Lifecore Biomedical's latest quarterly revenue breakdown by geography, as of Feb 23: SWITZERLAND (64.15%), IRELAND (10.38%), AUSTRALIA (10.38%), CZECHIA (6.60%), CANADA (6.60%), and All Other Countries (1.89%).

Lifecore Biomedical Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
CTLTCatalent$4.38B$1.07B
TLRYTilray Brands$788.94M$188.34M
IRWDIronwood Pharmaceuticals$442.74M$94.40M
KMDAKamada$144.76M$37.40M
LFCRLifecore Biomedical$128.26M$35.70M
ALIMAlimera Sciences$80.75M$23.01M
DERMJourney Medical$79.18M$14.86M
CPIXCumberland Pharmaceuticals$39.55M$9.85M
ADMPAdamis Pharmaceuticals$4.76M$9.06M
AKANAkanda$2.16M$762.61K
LSDILucy Scientific Discovery$7.05K$9.68K
SHPHShuttle Pharmaceuticals--

LFCR Revenue FAQ


Lifecore Biomedical's yearly revenue for 2024 was $128.26M, representing an increase of 24.20% compared to 2023. The company's yearly revenue for 2023 was $103.27M, representing a decrease of -44.42% compared to 2022. LFCR's yearly revenue for 2022 was $185.79M, representing a decrease of -65.86% compared to 2021.

Lifecore Biomedical's quarterly revenue for Q3 2024 was $35.7M, a 18.42% increase from the previous quarter (Q2 2024), and a 29.36% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $30.15M, a 22.95% increase from the previous quarter (Q1 2024), and a -22.30% decrease year-over-year (Q2 2023). LFCR's quarterly revenue for Q1 2024 was $24.52M, a -22.27% decrease from the previous quarter (Q4 2023), and a -43.44% decrease year-over-year (Q1 2023).

Lifecore Biomedical's revenue growth rate for the last 3 years (2022-2024) was -30.96%, and for the last 5 years (2020-2024) was -78.27%.